Metastatic Triple-Negative Breast Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11595Atezolizumab0Recruiting1
DB01229Paclitaxel0Recruiting1
DB08871Eribulin1Recruiting1
DB09074Olaparib1Active Not Recruiting1
DB06306Onalespib1Active Not Recruiting1
DB11595Atezolizumab1 / 2Recruiting1
DB01101Capecitabine1 / 2Recruiting1
DB00958Carboplatin1 / 2Recruiting1
DB11743Ipatasertib1 / 2Recruiting1
DB01229Paclitaxel1 / 2Recruiting1
DB00958Carboplatin2Not Yet Recruiting1
DB11059Carboxymethylcellulose2Not Yet Recruiting1
DB00482Celecoxib2Not Yet Recruiting1
DB11714Durvalumab2Not Yet Recruiting1
DB11714Durvalumab2Recruiting1
DB12078Enobosarm2Active Not Recruiting1
DB00783Estradiol2Recruiting1
DB00441Gemcitabine2Not Yet Recruiting1
DB05258Interferon alfa2Not Yet Recruiting1
DB00105Interferon alfa-2b2Not Yet Recruiting1
DB00123L-Lysine2Not Yet Recruiting1
DB09074Olaparib2Recruiting1
DB01229Paclitaxel2Not Yet Recruiting1
DB01229Paclitaxel2Recruiting1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Not Yet Recruiting1
DB05941LeronlimabNot AvailableAvailable1
DB12893Sacituzumab govitecanNot AvailableApproved for Marketing1